Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | STAT3 | P40763 | 1/20 | 0.61 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.60 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.60 |
| ▸ | ACVRL1 | P37023 | 4/20 | 0.59 |
| ▸ | F13A1 | P00488 | 1/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.57 |
| ▸ | KDR | P35968 | 5/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zeranol SCHEMBL9592548 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Taleranol SCHEMBL29554859 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL31122084 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL109174 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL10773090 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL343987 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL29554783 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL2602612 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL28985464 | 0.99 | LMNA (0.98) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL28584517 | 0.95 | LMNA (0.91) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122063208-A | Method for detecting zearalanol mycotoxin in traditional Chinese medicine preparation | 成都市药品检验研究院 | 2026-05-19 | — | — | CN | claimed |
| CN-120195313-A | Rapid screening method and screening database for food-borne stimulants in racing foods based on high-throughput technology | 成都市食品检验研究院 | 2025-06-24 | — | — | CN | claimed |
| CN-115718157-B | Improved method for measuring 15 mycotoxins in edible and medicinal substances by QuEChERS-UPLC-MS/MS | 南京师范大学 | 2025-05-30 | — | — | CN | claimed |
| CN-116087367-B | Method for simultaneously detecting multiple mycotoxins in traditional Chinese medicinal materials and preparations | 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） | 2025-02-25 | — | — | CN | claimed |
| CN-119355175-A | Method for non-targeted detection of 86 hormone interferents in aquatic ecosystem, hormone interferent ecological risk evaluation method and optimal control sequencing method | 成都市食品检验研究院 | 2025-01-24 | — | — | CN | claimed |
| CN-119000936-A | Method for rapidly determining 63 mycotoxins in edible and medicinal materials and grains | 成都市食品检验研究院 | 2024-11-22 | — | — | CN | claimed |
| CN-118641296-A | Method for preparing mass spectrum element for immunoseparating ionized zearalenone and application of mass spectrum element | 中国检验检疫科学研究院 | 2024-09-13 | — | — | CN | claimed |
| US-11998027-B2 | Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process | ERBER AKTIENGESELLSCHAFT (AT) | 2024-06-04 | — | — | US | claimed |
| US-11998028-B2 | Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process | ERBER AKTIENGESELLSCHAFT (AT) | 2024-06-04 | — | — | US | claimed |
| CN-117030909-A | Method for simultaneously detecting 24 food-derived stimulants in food | 成都市食品检验研究院 | 2023-11-10 | — | — | CN | claimed |
| US-20110212927-A1 | CARBONATE PRODRUGS AND METHODS OF USING THE SAME | NEUROGESX, INC. (US) | 2011-09-01 | — | — | US | claimed |
| CN-102149282-A | Carbonate prodrugs and methods of using the same | NEUROGESX INC | 2011-08-10 | — | — | CN | claimed |
| EP-2291084-A1 | CARBONATE PRODRUGS AND METHODS OF USING THE SAME | Neurogesx, Inc. (US) | 2011-03-09 | — | — | EP | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| WO-2009143297-A1 | CARBONATE PRODRUGS AND METHODS OF USING THE SAME | NEUROGESX, INC. (US) | 2009-11-26 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| EP-0332047-A2 | A process for the separation of macrocyclic diastereomers | C.R.C. Compagnia di Ricerca Chimica S.p.A. (IT) | 1989-09-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212927-A1 | CARBONATE PRODRUGS AND METHODS OF USING THE SAME | CA6, CA7, CA4 | LMNA 2401/4885SMN1; SMN2 2075/4885ESR2 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.